ArticleExpert review of precision medicine and drug development2018
The economic case for precision medicine.
Article in Expert review of precision medicine and drug development, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 3 syntheses or guidelines pooled it, 89 citations in OpenAlex.
- Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review.European journal of haematology · 2022Pooled it
- Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations.Lupus science & medicine · 2020Pooled it
- Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review.PharmacoEconomics · 2019Pooled it
- The dis-economy of precision medicine: how stratification multiplies social tension in healthcare systems.Medicine, health care, and philosophy · 2026Article
- Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and Trastuzumab Deruxtecan.Journal of clinical medicine · 2026Review
- How accurate should a precision medical test be to meet cost-effectiveness.Cost effectiveness and resource allocation : C/E · 2026Article
- Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers.Current issues in molecular biology · 2026Review
- Pharmacogenomics of treatment toxicities in pediatric B-Cell ALL: toward safer precision therapy.Frontiers in pharmacology · 2026Review
- Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping.International journal of environmental research and public health · 2025Review
- Ultrasound-guided synovial tissue biopsy for people with rheumatoid arthritis: a micro-costing study.Rheumatology advances in practice · 2025Article
- Current Role and Potential of Triple Quadrupole Mass Spectrometry in Biomedical Research and Clinical Applications.Molecules (Basel, Switzerland) · 2024Review
- Accuracy of machine learning in predicting outcomes post-percutaneous coronary intervention: a systematic review.AsiaIntervention · 2024Article
- Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis.Virchows Archiv : an international journal of pathology · 2024Article
- Development of a biomarker prediction model for post-trauma multiple organ failure/dysfunction syndrome based on the blood transcriptome.Annals of intensive care · 2024Article
- Artificial Intelligence Opportunities to Guide Precision Dosing Strategies.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024Article
- Evaluating Information Technology-enabled Precision Prevention Initiatives in Health and Care.Yearbook of medical informatics · 2024Article
- Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature.PharmacoEconomics · 2024Review
- A national framework for transition to precision medicine.Frontiers in medicine · 2024Article
- Prescription Precision: A Comprehensive Review of Intelligent Prescription Systems.Current pharmaceutical design · 2024Review
- Overcoming provider barriers to therapeutic drug monitoring of tumour necrosis factor inhibitors for rheumatoid arthritis: a qualitative analysis.Rheumatology advances in practice · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.